Clinical trial
Survey on Time to Lipid-lowering Drug Implementation on Dyslipidemic Patients in General Practice.
NCT00701402 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Survey on Time to Lipid-lowering Drug Implementation on Dyslipidemic Patients in General Practice.
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- January 31, 2009
- Enrollment
- 3,655 (actual)
- Sites
- 1,198
Conditions
As the registry lists them; a condition with its own page is linked.
dyslipidemia